ViH Articles

Future of Patients in Healthcare Evaluation: The Patient-Informed Reference Case

May 1, 2019, 00:00
Gastrointestinal Disorders - Clinical Outcomes

May 1, 2019, 00:00
PCV58 COST-EFFECTIVENESS OF POPULATION-WIDE GENOMIC SCREENING FOR FAMILIAL HYPERCHOLESTEROLEMIA

May 1, 2019, 00:00
Diabetes/Endocrine/Metabolic Disorders - Conceptual Papers (CP)

May 1, 2019, 00:00
PNS83 EXAMINING THE TEMPORAL IMPACT OF THE CMS SUNSHINE ACT ON THE INDUSTRY-PHYSICIAN RELATIONSHIP: AN UPDATED ANALYSIS

May 1, 2019, 00:00
PDG24 IMPACT OF BYPASSING MEDICATION DEDUCTIBLES AMONG MEMBERS ENROLLED IN HIGH DEDUCTIBLE HEALTH PLANS

May 1, 2019, 00:00
PND13 ESTIMATING STATE TRANSITIONS IN ALZHEIMER'S DISEASE BY AGE AND GENDER: ANALYSIS FROM A LONGITUDINAL COHORT

May 1, 2019, 00:00
PND50 PRESCRIPTION PATTERN OF ANTICHOLINERGIC DRUGS IN ALZHEIMER'S DISEASE

May 1, 2019, 00:00
Drugs Regulatory

May 1, 2019, 00:00
PCV33 HEALTH INSURANCE COST OF VENOUS EMBOLISM AND THROMBOSIS IN HUNGARY: COST OF ILLNESS STUDY BASED ON NATIONWIDE, REAL WORLD DATA

May 1, 2019, 00:00
PIH23 BUDGET IMPACT ANALYSIS OF SFLT-1/PLGF RATIO TO HELP RULE-OUT PRE-ECLAPMSIA IN WOMEN PRESENTING WITH SUSPECTED PRE-ECLAMPSIA IN THE PRIVATE HEALTHCARE SYSTEM IN BRAZIL

May 1, 2019, 00:00
Drugs Process of Care

May 1, 2019, 00:00
PIN32 DISEASE AND ECONOMIC BURDEN COST OF DENGUE ILLNESS IN INDIA: AN UPDATE FROM 2013 TO 2017

May 1, 2019, 00:00
PNS164 VALUATION OF PREDICTIVE MODELS IN HEALTHCARE: A REVIEW OF UTILITY METHODS

May 1, 2019, 00:00
PDB56 COSTS ASSOCIATED WITH INITIATING EMPAGLIFLOZIN VERSUS OTHER ANTIHYPERGLYCEMIC AGENTS IN PATIENTS WITH TYPE 2 DIABETES AND CARDIOVASCULAR DISEASE: A RETROSPECTIVE COHORT STUDY

May 1, 2019, 00:00
PND90 REAL WORLD REPLICATION OF CLINICAL TRIAL FINDINGS IN ALZHEIMER'S DISEASE

May 1, 2019, 00:00
PDB130 RISK EQUATIONS FOR COMPLICATIONS OF TYPE2 DIABETES USING REAL-WORLD ELECTRONIC MEDICAL RECORDS: LOCALIZED VS. GENERALIZABLE

May 1, 2019, 00:00
PDG21 COST-EFFECTIVENESS OF JINGSHU GRANULES FOR THE TREATMENT OF PATIENTS WITH CERVICAL RADICULOPATHY IN CHINA: A DECISION-TREE MODEL BASED ON RANDOMIZED CONTROLLED TRIAL

May 1, 2019, 00:00
PDG82 IMPACT OF STATIN ADHERENCE ON CLINICAL OUTCOMES IN NEWLY TREATED PATIENTS FOR PRIMARY AND SECONDARY PREVENTION: A RETROSPECTIVE STUDY BASED ON CLAIMS DATABASE IN CHINA

May 1, 2019, 00:00
PNS133 POLICIES TO IMPROVE AMR PRACTICES: AN INDUSTRY AND HCP PERSPECTIVE

May 1, 2019, 00:00
PNS167 A REVIEW OF EVALUATION CRITERIA AND STRATEGIES FOR INSURANCE COVERAGE OF PERSONALIZED MEDICINE: U.S. PAYER PERSPECTIVES

May 1, 2019, 00:00
PIN75 BABESIOSIS OCCURRENCE AMONG THE ELDERLY IN THE UNITED STATES: OVERALL, BY STATE, AND COUNTY OF RESIDENCE, AS RECORDED IN LARGE MEDICARE DATABASES DURING 2006-2017

May 1, 2019, 00:00
PNS190 PROPOSED MODELLING FRAMEWORK TO ASSESS THE VALUE OF A TREATMENT'S SAFETY PROFILE

May 1, 2019, 00:00
PPM4 COST-EFFECTIVENESS ANALYSIS OF NEXT GENERATION SEQUENCING PANEL OF CIRCULATING TUMOR DNA IN THE DIAGNOSIS OF PATIENT WITH METASTATIC NON-SQUAMOUS NON- SMALL CELL LUNG CANCER IN BRAZIL

May 1, 2019, 00:00
PMH35 TREATMENT-SEEKING BEHAVIOR AMONG UNIVERSITY STUDENTS REPORTING PAIN AND DEPRESSION

May 1, 2019, 00:00
PNS80 DEREGULATION AND ACCESS TO MEDICINES: THE CASE OF CHINA

May 1, 2019, 00:00
PCN303 COMPARATIVE ANALYSIS OF PROFILES OF 65+ YEAR OLD STAGE IV PROSTATE CANCER PATIENTS BY TIME FROM DIAGNOSIS TO FIRST TREATMENT IN THE UNITED STATES

May 1, 2019, 00:00
PND65 OPIOID AND OTHER ACUTE MEDICATION UTILIZATION AMONGST MIGRAINEURS IN AN EMPLOYED POPULATION

May 1, 2019, 00:00
PNS85 MARKET ACCESS TRENDS ACROSS THE EU5 AND US: 2009 TO 2018- AN UPDATE

May 1, 2019, 00:00
Multiple Diseases - Economic Evaluation

May 1, 2019, 00:00
Table of Contents

May 1, 2019, 00:00
PNS30 CAN AYUSHMANN BHARAT ALTER INDIA'S HEALTHCARE LANDSCAPE?

May 1, 2019, 00:00
PMU5 ASSESSMENT OF COMMUNITY PHARMACY PROFESSIONALSâ€™ KNOWLEDGE AND COUNSELING SKILLS ACHIEVEMENT TOWARDS HEADACHE MANAGEMENT: A CROSS-SECTIONAL AND SIMULATED-CLIENT BASED MIXED STUDY

May 1, 2019, 00:00
PMU65 ANALYSIS OF THE EARLY PERFORMANCE OF INTEGRATED CARE SYSTEMS IN THE UK USING A DIFFERENCE-IN-DIFFERENCES APPROACH

May 1, 2019, 00:00
PMH62 AN ASSESSMENT OF THE HUMANISTIC IMPACT OF SCHIZOPHRENIA IN RELATION TO CAREGIVER AND PRODUCTIVITY BURDEN

May 1, 2019, 00:00
PCV41 HEALTHCARE RESOURCE UTILIZATION AND ACUTE COSTS IN FRENCH PATIENTS WITH CORONARY ARTERY DISEASE AND PERIPHERAL ARTERY DISEASE

May 1, 2019, 00:00
PND31 ECONOMIC EVALUATION OF ABOBOTULINUM TOXIN A VS ONABOTULINUM TOXIN A IN REAL-LIFE CLINICAL MANAGEMENT OF POST-STROKE UPPER LIMB SPASTICITY

May 1, 2019, 00:00
PMU77 CELL AND GENE THERAPIES ARE ASSOCIATED WITH SUBSTANTIALLY LARGER QUALITY-ADJUSTED LIFE YEAR GAINS THAN CONVENTIONAL DRUGS AND BIOLOGICS

May 1, 2019, 00:00
PDB9 FACTORS ASSOCIATED WITH AND IMPLICATIONS OF MEETING OR NOT MEETING HBA1C TARGETS IN TYPE 2 DIABETES MELLITUS

May 1, 2019, 00:00
PIH48 A RETROSPECTIVE DATABASE ANALYSIS OF SHORT-ACTING AND LONG-ACTING OPIOID USE IN WOMEN WITH ENDOMETRIOSIS: II-PATTERNS OF UTILIZATION

May 1, 2019, 00:00
PND4 THE EFFECTIVENESS OF ANTIEPILEPTIC MEDICATIONS AS PROPHYLAXIS OF EARLY SEIZURE IN TRAUMATIC BRAIN INJURY PATIENTS COMPARED TO PLACEBO OR NO TREATMENT: A SYSTEMATIC REVIEW AND META-ANALYSIS

May 1, 2019, 00:00
PIH28 COST-EFFECTIVENESS OF INHALED NITRIC OXIDE FOR TREATMENT OF INFANTS WITH HYPOXIC RESPIRATORY FAILURE: ADMINISTRATION AT HOSPITAL OF BIRTH VS. HELICOPTER TRANSFER TO ANOTHER HOSPITAL

May 1, 2019, 00:00
PCN301 DEVELOPMENT OF PLAYBOOK FOR CHART REVIEW IN REAL WORLD DATA

May 1, 2019, 00:00
PMU48 THE AFFORDABLE CARE ACT AND OUTBOUND MEDICAL TRAVEL FROM THE UNITED STATES

May 1, 2019, 00:00
PNS183 WHAT METHODS ARE APPLIED IN ASSESSESSING THE CLINICAL AND COST EFFECTIVENESS OF HEALTH TECHNOLOGIES BASED ON THE USE OF SURROGATE OUTCOMES: A COMPARISON OF EVALUATION REPORTS ACROSS INTERNATIONAL HEALTH TECHNOLOGY ASSESSMENT AGENCIES ...

May 1, 2019, 00:00
PND91 PREDICTORS OF NON-ADHERENCE AMONG PATIENTS WITH MULTIPLE SCLEROSIS NEWLY INITIATING ONCE- OR TWICE-DAILY ORAL DISEASE-MODIFYING DRUGS

May 1, 2019, 00:00
PNS49 WHAT'S TRENDING? PHARMACOECONOMIC PUBLICATIONS IN THE US BETWEEN 2009–2018

May 1, 2019, 00:00
PDB113 EVOLVING OUR UNDERSTANDING OF THE PATIENT EXPERIENCE OF HYPOGLYCEMIC EVENTS

May 1, 2019, 00:00
PDB61 COMPARE LIXISENATIDE WITH RAPID-ACTING INSULIN INTENSIFICATION REGIMENS ON TOP OF BASAL INSULIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A COST PER RESPONDER AND NUMBER NEEDED TO TREAT ANALYSIS IN CHINA

May 1, 2019, 00:00
Multiple Diseases - Epidemiology Public Health

May 1, 2019, 00:00
PPM3 COST-EFFECTIVENESS OF SCREENING AND MANAGEMENT STRATEGIES FOR FAMILIAL HYPERCHOLESTEROLEMIA IN THE UNITED STATES: AN UPDATE

May 1, 2019, 00:00
Diabetes/Endocrine/Metabolic Disorders - Medical Technologies

May 1, 2019, 00:00
PND33 FINANCIAL ACCESS TO AND RACIAL/ETHNIC DISPARITIES IN HEALTHCARE UTILIZATION AMONG PATIENTS WITH DEMENTIA

May 1, 2019, 00:00
Diabetes/Endocrine/Metabolic Disorders - Clinical Outcomes

May 1, 2019, 00:00
Medical Devices - Epidemiology Public Health

May 1, 2019, 00:00
PMU37 ASSOCIATION OF OSTEOARTHRITIS AND PAIN WITH ALZHEIMER'S DISEASES AND RELATED DEMENTIAS AMONG OLDER ADULTS IN THE UNITED STATES

May 1, 2019, 00:00
PMH56 PATIENT REPORTED OUTCOMES (PRO) COLLECTED AS PART OF THE CLINICAL PROCESS: THE CHALLENGE OF ADMINISTERING, SCORING, STORING, AND INTERPRETING PHQ-9 SCORES BEYOND THE CLINICAL MOMENT

May 1, 2019, 00:00
PCV3 THROMBOPROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN ACUTE MEDICALLY ILL PATIENTS: A NETWORK META-ANALYSIS

May 1, 2019, 00:00
PDB39 THE BURDEN OF HYPOGLYCEMIC EVENTS DURING AN INPATIENT HOSPITAL STAY IN PATIENTS WITH DIABETES USING INSULIN: A U.S. RETROSPECTIVE DATABASE ANALYSIS

May 1, 2019, 00:00
PNS122 REGULATORY BASIS FOR THE ORGANIZATION OF RISK-SHARING SCHEMES IN THE RUSSIAN FEDERATION

May 1, 2019, 00:00
PIN99 DETAILED INSIGHT FROM ELECTRONIC HEALTH RELATED QUALITY OF LIFE DATA IN HIV FOR PAYER DECISION MAKING — A WAY TO BETTER ALLOCATE RESOURCES AND SUPPORT PATIENTS

May 1, 2019, 00:00
PMU43 DISEASE PRIORITISATION MCDA MODEL FOR INFORMING HEALTHCARE PRIORITIES SETTING IN UKRAINE

May 1, 2019, 00:00
PDB10 PROGRESSION FROM METABOLIC SYNDROME TO NON-ALCOHOLIC FATTY LIVER DISEASE: ANALYSES IN AN EMR-CLAIMS DATABASE

May 1, 2019, 00:00
PND18 CLINICAL AND ECONOMIC IMPACT OF INITIATING DIMETHYL FUMARATE VERSUS OTHER DISEASE MODYFING THERAPIES IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN GERMANY

May 1, 2019, 00:00
Cardiovascular Disorders - Patient-Centered Research

May 1, 2019, 00:00
PCN233 SOCIETAL BURDEN OF BREAST CANCER: IMPACT ON THE BRAZILIAN SOCIAL SECURITY SYSTEM

May 1, 2019, 00:00
PGI2 USE OF DIFFERENT STATISTICAL APPROACHES TO COMPARE REAL-WORLD OUTCOMES ASSOCIATED WITH VEDOLIZUMAB VERSUS INFLIXIMAB IN BIOLOGIC-NAIVE PATIENTS WITH INFLAMMATORY BOWEL DISEASE

May 1, 2019, 00:00
PCN260 THE CONTRIBUTION OF FUNCTION-RELATED INDICATORS (FRI) IN IDENTIFYING AND MODELING PATIENT COMPLEXITY

May 1, 2019, 00:00
PCV4 REAL WORLD EVIDENCE OF RECURRENT VENUS THROMBOEMBOLISM (RVTE) IN ELDERLY PATIENTS: DIFFERENCES BY PHARMACOLOGIC PROPHYLAXIS TREATMENT

May 1, 2019, 00:00
PNS250 USING TOOLS OF BEHAVIORAL SCIENCE TO IMPROVE PATIENT ENGAGEMENT, RETENTION AND ADHERENCE

May 1, 2019, 00:00
PND11 HEALTHCARE RESOURCE UTILIZATION AND CLINICAL OUTCOMES IN HOSPITALIZED PATIENTS WITH HEPATIC ENCEPHALOPATHY IN THE UNITED STATES: A NATIONWIDE STUDY

May 1, 2019, 00:00
PGI13 MEDICATION USE AND HEALTHCARE RESOURCE UTILIZATION TRENDS AMONG ADULT ULCERATIVE COLITIS PATIENTS IN THE UNITED STATES: 2007-2017

May 1, 2019, 00:00
PDB8 USING REAL WORLD DATA (RWD) TO IDENTIFY SUBPOPULATIONS OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND ASSOCIATIONS WITH CARDIOVASCULAR (CV) AND LIVER-RELATED OUTCOMES

May 1, 2019, 00:00
PDB96 BUDGET IMPACT MODELLING OF POINT-OF-CARE HBA1C MONITORING OF PATIENTS WITH DIABETES MELLITUS TYPE II IN MID-INCOME COUNTRIES

May 1, 2019, 00:00
Individual's Health - Economic Evaluation

May 1, 2019, 00:00
PDB59 LIXISENATIDE, BASAL INSULIN AND PREMIXED INSULIN FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED BY ORAL ANTIDIABETIC DRUGS: NETWORK META-ANALYSIS AND COST-EFFECTIVENESS ANALYSIS

May 1, 2019, 00:00
PCV78 RISK FACTORS FOR DECOMPENSATION AND CARDIOVASCULAR MORTALITY IN HEART FAILURE PATIENTS WITH REDUCED OR PRESERVED EJECTION FRACTION

May 1, 2019, 00:00
PDB105 HEMOGLOBIN A1C (HBA1C) TESTING FREQUENCY AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS WITH TYPE 2 DIABETES: AN ELECTRONIC HEALTH RECORDS LINKED WITH PATIENT-REPORTED OUTCOMES STUDY

May 1, 2019, 00:00
PNS66 EQ-5D DERIVED POPULATION NORMS OF GENERAL POPULATION OF AZAD JAMMU AND KASHMIR (AJK) BY DEMOGRAPHIC CHARACTERISTICS

May 1, 2019, 00:00
PCN284 PSYCHOMETRIC EVALUATION AND SCORE INTERPRETATION OF THE NCCN-FACT OVARIAN SYMPTOM INDEX-18 IN PATIENTS WITH ADVANCED OVARIAN CANCER: REAL-WORLD EVIDENCE

May 1, 2019, 00:00
PNS53 ADHERENCE OF 2017-PUBLISHED COST-EFFECTIVENESS ANALYSIS (CEA) ARTICLES TO METHODOLOGICAL STANDARDS FOR INCREMENTAL COST-EFFECTIVENESS RATIOS (ICERS) AND OTHER METHODS-ORIENTED QUALITY ATTRIBUTES

May 1, 2019, 00:00
PND27 ECONOMIC BURDEN OF PROBABLE LENNOX-GASTAUT SYNDROME, PROBABLE DRAVET SYNDROME, AND OTHER REFRACTORY EPILEPSIES FOR UNITED STATES COMMERCIAL HEALTH PLANS

May 1, 2019, 00:00
PMS12 TOCILIZUMAB IN MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS: SYSTEMATIC REVIEW OF EFFICACY AND SAFETY

May 1, 2019, 00:00
PIN50 ECONOMIC OUTCOMES OF PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA (CAP) HOSPITALIZATIONS IN THE US: A RETROSPECTIVE COHORT STUDY, 2012-2017

May 1, 2019, 00:00
PMD20 CENTRIFUGAL VERSUS MEMBRANE THERAPEUTIC PLASMA EXCHANGE: SINGLE CENTER COST BENEFIT ANALYSIS IN THAILAND

May 1, 2019, 00:00
NO Specific Disease - Patient-Centered Research

May 1, 2019, 00:00
PNS175 A DESCRIPTIVE ANALYSIS OF ICER ACCEPTANCE OF PHARMACEUTICAL MANUFACTURERS COMMENTS

May 1, 2019, 00:00
PMU26 HEALTHCARE RESOURCE UTILIZATION AND CLINICAL OUTCOMES IN HOSPITALIZED PATIENTS WITH ALZHEIMER'S DISEASE AND RELATED DEMENTIAS IN THE UNITED STATES: A NATIONWIDE RETROSPECTIVE COHORT STUDY

May 1, 2019, 00:00
Injury Trauma - Economic Evaluation

May 1, 2019, 00:00
PDG79 MULTIVARIATE NETWORK META-ANALYSIS MODELS THAT INCORPORATE MULTIPLE OUTCOMES CAN PRODUCE MORE ACCURATE COMPARATIVE EFFECTIVENESS ESTIMATES THAN STANDARD UNIVARIATE MODELS

May 1, 2019, 00:00
PMH12 COST-EFFECTIVENESS OF PALIPERIDONE PALMITATE 3-MONTH VERSUS 1-MONTH FOR THE TREATMENT OF SCHIZOPHRENIA IN THE UNITED STATES

May 1, 2019, 00:00
PIT18 INCREASING BURDEN OF MAJOR TRAUMA IN TAIWAN: TIME TREND OF INCIDENCE RATE AND LIFE EXPECTANCY LOSS

May 1, 2019, 00:00
PIN42 THE IMPACT OF DIGITAL MEDICINE PROGRAM ON ECONOMIC AND PUBLIC HEALTH BENEFITS FOR HCV COVERAGE EXPANSION FROM A STATE MEDICAID PERSPECTIVE

May 1, 2019, 00:00
PMU91 USING HIGH POWERED ANALYTICS AND CUSTOMER RELATIONSHIP MANAGEMENT (CRM) TOOLS TO PROVIDE A BETTER MEMBER EXPERIENCE: BCBSLA MAKING A DIFFERENCE

May 1, 2019, 00:00
PIN49 EXAMINING THE CLINICAL AND ECONOMIC IMPACT OF ANTIMICROBIAL RESISTANCE AT ACUTE CARE FACILITIES: A PRACTICAL TOOL

May 1, 2019, 00:00
PIH8 NOVEL MEASUREMENT STRATEGIES FOR COLLECTION OF CLINICAL OUTCOME ASSESSMENTS IN A PEDIATRIC POPULATION

May 1, 2019, 00:00
PMU6 ASSOCIATION OF POWERED STAPLING TECHNOLOGY WITH ECONOMIC AND CLINICAL OUTCOMES: EVIDENCE FROM REAL-WORLD ASSESSMENTS OF BARIATRIC, RIGHT COLORECTAL, AND THORACIC LOBECTOMY PROCEDURES CONDUCTED VIA MINIMALLY-INVASIVE APPROACHES

May 1, 2019, 00:00
PNS178 CONSUMER HEALTH INFORMATION TECHNOLOGY IN THE PREVENTION OF SUBSTANCE ABUSE: A SCOPING REVIEW

May 1, 2019, 00:00
PDB120 UNDERSTANDING PATIENTS' WILLINGNESS TO PAY (WTP) FOR BIPHASIC INSULIN ASPART 30/70 (BIASP30) IN A FLEXPEN® DEVICE OR USING A PENFILL® FOR TYPE 2 DIABETES (T2D) TREATMENT IN AN OUT-OF-POCKET PAYMENTS MARKET

May 1, 2019, 00:00
Infectious Diseases - Epidemiology Public Health

May 1, 2019, 00:00
Drugs Statistical Research

May 1, 2019, 00:00
PMU113 THE COST OF MEDICAL TELECONSULTATIONS OF A BRAZILIAN GOVERNMENT EHEALTH SERVICE

May 1, 2019, 00:00
PNS255 PATIENTS RELATED ISSUES ARISING FROM REGULATORY APPROVAL, PRICING AND LAUNCH PLAN OF PHARMACEUTICAL PRODUCTS

May 1, 2019, 00:00
PIH52 DEMENTIA-RELATED PSYCHOSIS: REAL-WORLD PATIENT CHARACTERISTICS AND HEALTHCARE UTILIZATION FROM A LARGE US ADMINISTRATIVE CLAIMS DATABASE

May 1, 2019, 00:00
PMD29 HOSPITAL RELATED CLINICAL AND ECONOMICAL OUTCOMES OF A OXIDIZED ZIRCONIUM HIP SYSTEM IN TOTAL HIP ARTHROPLASTY PATIENTS

May 1, 2019, 00:00
PMD34 COMPARISON OF MEDICAL RESOURCE UTILIZATION AND COSTS BETWEEN PATIENTS WITH EARLY POSTOPERATIVE PERIPROSTHETIC HIP FRACTURES AND THOSE WITHOUT FOLLOWING TOTAL HIP ARTHROPLASTY: A MULTILEVEL MATCHED ANALYSIS

May 1, 2019, 00:00
PNS117 PATIENT, PAYER AND MANUFACTURER PERSPECTIVES ON FOUR COST-CONTROL MECHANISMS FOR PHARMACEUTICALS

May 1, 2019, 00:00
Neurological Disorders - Real World Data Information Systems

May 1, 2019, 00:00
PNS266 LANDSCAPE ANALYSIS OF IMPACT OF MACHINE LEARNING, NATURAL LANGUAGE PROCESSING, ARTIFICIAL INTELLIGENCE AND BLOCKCHAIN TECHNOLOGY ON LEVERAGING REAL WORLD EVIDENCE (RWE)

May 1, 2019, 00:00
PCN238 CANCER PATIENT ENGAGEMENT IN 2018 - COMMUNITY PROVIDERS PERSPECTIVES ON DIGITAL DATA AND COMMUNICATION AT THE BEDSIDE

May 1, 2019, 00:00
PND19 CLINICAL AND ECONOMIC IMPACT OF INITIATING DIMETHYL FUMARATE VERSUS GLATIRAMER ACETATE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN EUROPE

May 1, 2019, 00:00
Multivariable and Structural Uncertainty Analyses for Cost-Effectiveness Estimates: Back to the Future

May 1, 2019, 00:00
PND64 TRENDS AND DISPARITIES IN PHARMACEUTICAL TREATMENT FOR ALZHEIMERâ€™S DISEASE AND RELATED DEMENTIA PATIENTS

May 1, 2019, 00:00
PCV12 COMPARATIVE EFFECTIVENESS AND SAFETY OF NON-VITAMIN K ANTAGONISTS VERSUS WARFARIN IN ELDERLY PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION AND DIABETES

May 1, 2019, 00:00
PMS47 SEXUAL FUNCTION IN PSORIATIC ARTHRITIS: A PATIENT REPORTED OUTCOMES REVIEW

May 1, 2019, 00:00
PCV105 EXAMINING THRESHOLDS FOR THE RENIN-ANGIOTENSIN SYSTEM ANTAGONIST MEDICATION ADHERENCE QUALITY MEASURE: THE APPLICATION OF THE LAW OF DIMINISHING RETURNS TO OPTIMIZE ADHERENCE-ASSOCIATED ECONOMIC OUTCOMES

May 1, 2019, 00:00
PCV59 ESTIMATING ECONOMIC AND HEALTH OUTCOMES ASSOCIATED WITH ADHERENCE TO TREATMENT FOR HYPERTENSION

May 1, 2019, 00:00
Mental Health - Real World Data Information Systems

May 1, 2019, 00:00
Mental Health - Medical Technologies

May 1, 2019, 00:00
PDG44 DRUG INFORMATION ON THE INTERNET - CONSISTENTLY INCONSISTENT RESULTS: CONTENT ANALYSIS USING THREE MAJOR SEARCH ENGINES

May 1, 2019, 00:00
PNS33 BUGSNET: A NEW COMPREHENSIVE R PACKAGE FOR NETWORK META-ANALYSIS

May 1, 2019, 00:00
PMS22 CLINICAL AND COST EFFECTIVENESS OF PHYSIOTHERAPY INTERVENTIONS FOLLOWING TOTAL KNEE REPLACEMENT- A SYSTEMATIC REVIEW AND META-ANALYSIS

May 1, 2019, 00:00
PCN285 KNOWLEDGE AND AWARENESS OF MISMATCH REPAIR/MICROSATELLITE INSTABILITY (MMR/MSI) TESTING AMONG US PATIENTS WITH ADVANCED/METASTATIC COLORECTAL CANCER (MCRC)

May 1, 2019, 00:00
PCV29 HOSPITAL BUDGET IMPACT OF SWITCHING TO AN ALTERNATIVE ASPIRIN FORMULATION WITH IMPROVED GI SAFETY FOR TREATMENT OF ACUTE CARDIOVASCULAR EVENTS

May 1, 2019, 00:00
PIN30 IMPACT OF DISEASE SEVERITY ON HEALTHCARE COSTS IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION (HCV)

May 1, 2019, 00:00
PCN232 DIVERGENT HTA DECISIONS IN EUROPE FOR ONCOLOGY DRUGS GRANTED BREAKTHROUGH DESIGNATION

May 1, 2019, 00:00
Musculoskeletal Disorders - Clinical Outcomes

May 1, 2019, 00:00
PDB33 USING REAL WORLD DATA TO ESTIMATE THE POTENTIAL IMPACT OF TYPE 2 DIABETES RELATED COMPLICATIONS IN DIABETIC PATIENTS FROM THE PERSPECTIVE OF PUBLIC HEALTH SYSTEM IN CHILE.

May 1, 2019, 00:00
PIH24 COST OF TREATING IRON DEFICIENCY ANAEMIA (IDA) WITH FERRIC CARBOXYMALTOSE VERSUS IRON SACCHARATE IN HEAVY UTERINE BLEEDING (HUB) PATIENTS IN THE KINGDOM OF SAUDI ARABIA

May 1, 2019, 00:00
PMS3 A LOW-COST MODEL OF ADHERENCE/ATTENDANCE OF PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING BIOLOGICAL THERAPY IN A SPECIALIZED CENTER

May 1, 2019, 00:00
PND51 PATTERNS OF ANTIDEMENTIAL DRUG USE IN A GROUP OF PATIENTS FROM COLOMBIA

May 1, 2019, 00:00
PIN90 HEALTH-ECONOMIC MODELLING TO INFORM PRIVATE SECTOR INVESTMENT IN INFECTIOUS DISEASE TREATMENTS IN MIDDLE-INCOME COUNTRIES: THE CASE OF TUBERCULOSIS

May 1, 2019, 00:00
PNS135 ATTITUDES TOWARD DRUG PRICING IN THE US: FINDINGS FROM A SURVEY IN THE GENERAL POPULATION

May 1, 2019, 00:00
PMD46 UNDERSTANDING DISCRETE CHOICE PREFERENCES FOR A NOVEL PROSTHETIC DEVICE IN PERSONS WITH LOWER LIMB LOSS

May 1, 2019, 00:00
PMH22 IS INCREASED SEVERITY STATUS ASSOCIATED WITH INCREMENTAL ECONOMIC BURDEN IN PRIVATELY INSURED US PATIENTS WITH TREATMENT RESISTANT DEPRESSION?

May 1, 2019, 00:00
PCV54 COST-EFFECTIVENESS OF ASPIRIN FOR PRIMARY PREVENTION OF CARDIOVASCULAR EVENTS IN CHINESE PATIENTS WITH DIABETES

May 1, 2019, 00:00
PMD11 TOTAL HIP REPLACEMENT: RISK AND BURDEN OF POST-SURGICAL DEEP AND SUPERFICIAL INFECTION

May 1, 2019, 00:00
PNS243 REVIEW OF PATIENT REPORTED OUTCOME (PRO) MEASURES FOR NOVEL DRUG APPROVALS (NDA) IN THE UNITED STATES: 2016-2018

May 1, 2019, 00:00
PDB119 CLINICAL USE OF FAST-ACTING INSULIN ASPART IN PEOPLE WITH TYPE 1 AND TYPE 2 DIABETES, A SURVEY OF PHYSICIANS' EXPERIENCES AND TREATMENT SATISFACTION

May 1, 2019, 00:00
PNS148 EDUCATING PUBLIC ABOUT DISABILITY AND GIVING PEOPLE WITH DISABILITY THE SAME OPPORTUNITY AS PEOPLE WITHOUT DISABILITY: DESCRIPTIVE ANALYSIS.

May 1, 2019, 00:00
PIH53 PATTERNS AND PREDICTORS OF OFF-LABEL ANTIPSYCHOTIC USE AMONG OLDER ADULTS WITH DEMENTIA IN AMBULATORY CARE SETTINGS IN THE UNITED STATES (US)

May 1, 2019, 00:00
PDG31 ESTIMATING COSTS OF CLUSTERED OUTPATIENT ADVERSE DRUG REACTIONS WITHIN THE VETERANS HEALTH ADMINISTRATION USING THE VA ADVERSE DRUG EVENT REPORTING SYSTEM

May 1, 2019, 00:00
PGI5 LONG TERM ECONOMIC VALUE OF TIGHT CONTROL WITH ADALIMUMAB-BASED TREATMENT IN CROHN'S DISEASE: THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE

May 1, 2019, 00:00
PNS96 NICE SOCIAL MEDIA - IMPACT OF AD-HOC PUBLIC COMMENTS ON HST RECOMMENDATIONS

May 1, 2019, 00:00
PNS74 GENDER DIFFERENCES IN THE ASSOCIATION OF CURRENT SMOKING WITH SOCIOECONOMIC FACTORS IN A REPRESENTATIVE JAPANESE POPULATION

May 1, 2019, 00:00
PNS97 LEVERAGING DATA-DRIVEN INSIGHTS TO SUPPORT DEVELOPMENT OF TARGETED SUPPLEMENTAL BENEFITS UNDER NEWLY EXPANDED FLEXIBILITIES IN MEDICARE ADVANTAGE TO IMPROVE OUTCOMES IN HIGH-COST, HIGH-NEED BENEFICIARIES

May 1, 2019, 00:00
PMD31 SWIPING RIGHT ON MEDICAL TECHNOLOGY; AN ANALYSIS OF DRUG VS. DEVICE HTA APPROVALS IN CANADA

May 1, 2019, 00:00
PNS140 PHARMACY PATRONAGE: ASSESSING HOW RESPONDENTS SELECT THEIR PHARMACY USING THE DETERMINANT ATTRIBUTE APPROACH

May 1, 2019, 00:00
PCV48 THE INFLUENCE OF THE SOCIO-ECONOMIC STATUS IN THE DISEASE BURDEN OF CARDIOVASCULAR DISEASES IN THE UNITED STATES

May 1, 2019, 00:00
PND41 HEALTHCARE EXPENDITURE BURDEN IN MULTIPLE SCLEROSIS: MARGINAL COSTS BASED ON NATIONAL LEVEL DATA

May 1, 2019, 00:00
PNS202 THE DEVELOPMENT OF A HEALTH ECONOMIC MODEL MARKUP LANGUAGE AS A FOUNDATION FOR MODEL TRANSPARENCY

May 1, 2019, 00:00
PIH68 DO PATIENT CONCERNS ABOUT ANTIHYPERTENSIVE USE AS A DEMENTIA PREVENTION STRATEGY VARY BY CURRENT USE OF ANTIHYPERTENSIVE MEDICATION?

May 1, 2019, 00:00
PGI8 BUDGET IMPACT ANALYSIS OF LINX REFLUX MANAGEMENT SYSTEM FOR THE TREATMENT OF MEDICATION-REFRACTORY MECHANICAL GASTROESOPHAGEAL REFLUX DISEASE: A U.S. PAYER PERSPECTIVE

May 1, 2019, 00:00
Looking Backward 2143-1943: The Rise and Fall of the RCT

May 1, 2019, 00:00
PNS236 RAPID WEIGHT GAIN AND HEALTH-RELATED QUALITY OF LIFE: RESULTS FROM LINKING ELECTRONIC HEALTH RECORDS TO PATIENT-REPORTED OUTCOMES

May 1, 2019, 00:00
PIH43 ASSOCIATION OF SLEEP QUALITY TO TELOMERE LENGTH, A MARKER OF CELLULAR AGING. A RETROSPECTIVE COHORT STUDY OF OLDER ADULTS IN THE UNITED STATES

May 1, 2019, 00:00
PIH44 IMPACTS OF THE ENVIRONMENTAL POLICY ON INFANT MORTALITY IN THE UNITED STATES

May 1, 2019, 00:00
Medical Devices - Health Service Delivery Process of Care

May 1, 2019, 00:00
PIN100 IMPACT OF CHRONIC HEPATITIS B VIRUS INFECTION ON HEALTH-RELATED QUALITY OF LIFE: A LITERATURE REVIEW

May 1, 2019, 00:00
PMH29 OPIOID USE AMONG INDIVIDUALS WITH DEPRESSION:NHAES STUDY 2005-2014

May 1, 2019, 00:00
PMH45 PREDICTORS OF ANTIMUSCARNIC MEDICATION USE AMONG ELDERLY DEMENTIA PATIENTS WITH OVERACTIVE BLADDER: A RETROSPECTIVE STUDY OF MEDICARE BENEFICIARIES

May 1, 2019, 00:00
PDG90 OPIOID USE AMONG MIGRAINE PATIENTS PRESENTING TO THE EMERGENCY DEPARTMENT (ED) OF A LARGE TERTIARY CARE INTEGRATED DELIVERY NETWORK IN TEXAS

May 1, 2019, 00:00
PND38 EVALUATION OF DEMENTIA INFORMAL CAREGIVERS WILLINGNESS TO PAY FOR A NONPHARMACOLOGIC INTERVENTION TO REDUCE BEHAVIORAL SYMPTOMS

May 1, 2019, 00:00
PDB65 NON-ALCOHOLIC STEATOHEPATITIS (NASH): US PAYER VALUE AND COVERAGE OF POTENTIAL NASH THERAPIES

May 1, 2019, 00:00
PIN85 GLOBAL COMPLIANCE WITH HEPATITIS B VACCINE BIRTH DOSE AND FACTORS RELATED TO TIMELY SCHEDULE. A LITERATURE REVIEW

May 1, 2019, 00:00
PIN22 COST-EFFECTIVENESS OF DIRECT-ACTING ANTIVIRALS FOR CHRONIC HEPATITIS C TREATMENT-NAIVE PATIENTS IN CHINA

May 1, 2019, 00:00
PIN69 RACIAL DISPARITIES IN RECORDING ANTIMICROBIAL RESISTANCE AMONG OLDER PEOPLE WITH URINARY TRACT INFECTIONS

May 1, 2019, 00:00
PIN18 COSTS OF ADULT VACCINATION IN MEDICAL SETTINGS AND PHARMACIES: AN OBSERVATIONAL STUDY

May 1, 2019, 00:00
Infectious Diseases - Real World Data Information Systems

May 1, 2019, 00:00
PMH65 ASSESSMENT OF OUTCOMES AND SYMPTOM SEVERITY IN SCHIZOPHRENIA PATIENTS ACCORDING TO PHYSICIAN PERCEPTION OF ILLNESS

May 1, 2019, 00:00
PIN60 LYME DISEASE FIRST-LINE TREATMENT AND PROGRESSION IN FLORIDA AND THE NORTHEASTERN US: A COMPARISON USING REAL-WORLD DATA

May 1, 2019, 00:00
Individual's Health - Epidemiology Public Health

May 1, 2019, 00:00
PDB58 GESTATIONAL DIABETES SCREENING IN CHINA: A COST-EFFECTIVENESS STUDY

May 1, 2019, 00:00
PIN94 MEASURING ADHERENCE TO TREATMENT IN HIV USING A REGIMEN BASED APPROACH

May 1, 2019, 00:00
PCV66 BASELINE CHARACTERISTICS AMONG VENTRICULAR TACHYCARDIA ABLATION PATIENTS: A MULTI-HOSPITAL DATABASE ANALYSIS

May 1, 2019, 00:00
PMS21 HOW EXPENSIVE IS TREATING PATIENTS IN A CENTER OF EXCELLENCE FOR RHEUMATOID ARTHRITIS IN COLOMBIA?

May 1, 2019, 00:00
PGI3 INDIRECT TREATMENT COMPARISONS AND NETWORK META-ANALYSES OF NALDEMEDINE FOR THE TREATMENT OF OPIOID-INDUCED CONSTIPATION

May 1, 2019, 00:00
AD4 THE IMPACT OF MEDICARE STAR RATING ADHERENCE MEASURES ON MEDICATION ADHERENCE FOR TARGETED AND NON-TARGETED MEDICATIONS

May 1, 2019, 00:00
PNS52 CAN COST-EFFECTIVENESS ANALYSIS INFORM THE EXTENT OF COVERAGE UNDER PUBLIC HEALTHCARE? A MICROSIMULATION MODEL OF ALTERNATIVE PRENATAL SCREENING AND DIAGNOSTIC STRATEGIES

May 1, 2019, 00:00
PMD45 PAIN RELIEF AND FUNCTION RESTORATION AFTER PRIMARY TOTAL KNEE ARTHROPLASTY: AN EVALUATION USING KNEE INJURY AND OSTEOARTHRITIS OUTCOME SCORE IN REAL WORLD DATA

May 1, 2019, 00:00
Neurological Disorders - Economic Evaluation

May 1, 2019, 00:00
PMU84 TARGETED LITERATURE REVIEW OF TIME UTILIZATION ASSOCIATED WITH THE USE OF PREFILLED SYRINGES VERSUS CONVENTIONAL SYRINGES

May 1, 2019, 00:00
PMU64 THE IMPACT OF FORMULARY RESTRICTIONS ON LIKELIHOOD OF SUCCESSFUL DISPENSATION OF ANTIEPILEPTIC DRUG TREATMENT IN A PEDIATRIC PATIENT POPULATION

May 1, 2019, 00:00
PMD49 IMPACT OF SURGICEL ON SURGICAL OUTCOMES AND HOSPITAL COSTS ASSOCIATED WITH OPEN GASTRECTOMY IN A CHINESE TIER III TERTIARY CARE HOSPITAL

May 1, 2019, 00:00
PMH67 USING REAL WORLD DATA TO PROFILE CURRENT STANDARD OF CARE FOR SCHIZOPHRENIA PATIENTS AT A MENTAL HEALTH HOSPITAL IN RWANDA, AFRICA

May 1, 2019, 00:00
PIN48 A COST-EFFECTIVENESS ANALYSIS FOR INFLUENZA VIRUS INFECTION WITH OSELTAMIVIR OR BALOXAVIR IN JAPAN

May 1, 2019, 00:00
Multiple Diseases - Medical Technologies

May 1, 2019, 00:00
PDB106 QUALITY OF LIFE AND TREATMENT SATISFACTION IN PATIENTS WITH DIABETES AND CONTINUOUS SUBCUTANEOUS INSULIN PUMP / REAL TIME - CONTINUOUS GLUCOSE MONITORING

May 1, 2019, 00:00
PMH27 RELATIONSHIP BETWEEN DISENGAGEMENT BELIEFS, PERCEIVED RISKS-BENEFITS, SMOKING SELF-EFFICACY AND MOTIVATION TO QUIT SMOKING AMONG ADULT SMOKERS

May 1, 2019, 00:00
Medical Devices - Health Technology Assessment

May 1, 2019, 00:00
PCV25 DISEASE BURDEN OF HEART FAILURE IN A DEVELOPING COUNTRY

May 1, 2019, 00:00
PCV88 REAL-WORLD STUDY OF TREATMENT INTENSIFICATION OF STATINS IN PATIENTS WITH UNCONTROLLED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)

May 1, 2019, 00:00
PDB116 REAL-WORLD ADHERENCE AND PERSISTENCE AMONG ELDERLY PATIENTS WITH T2DM INITIATING DULAGLUTIDE VS. LIRAGLUTIDE OR EXENATIDE ONCE-WEEKLY IN THE US

May 1, 2019, 00:00
PDG49 UNINTENTIONAL AND SUICIDAL OPIOID OVERDOSE IN MEDICARE BENEFICIARIES

May 1, 2019, 00:00
PDG40 PRESCRIPTION OPIOID MEDICATION EXPOSURE AMONG MEDICARE BENEFICIARIES

May 1, 2019, 00:00
PMS31 IMPACT OF OPIOID DOSE ESCALATION ON THE DEVELOPMENT OF SUBSTANCE USE DISORDERS, ACCIDENTS, SELF-INFLICTED INJURIES, OPIOID OVERDOSES, AND ALCOHOL AND NON-OPIOID DRUG-RELATED OVERDOSES: A RETROSPECTIVE COHORT STUDY

May 1, 2019, 00:00
PCV9 UNMET NEEDS BURDEN OF RECURRENT PERICARDITIS (RP): RESULTS OF A SYSTEMATIC LITERATURE REVIEW (SLR)

May 1, 2019, 00:00
PMU20 CONSTRAINED OPTIMIZATION FOR IDENTIFYING THE COMBINATION OF PNEUMOCOCCAL VACCINATION SCHEMES WHICH MAXIMIZES QALY-GAINS OVER THE NEXT 10 YEARS IN BRAZIL

May 1, 2019, 00:00
PCV110 DEMOGRAPHIC AND CLINICAL PROFILES OF VERY-HIGH-RISK ATHEROSCLEROSIS PATIENTS AND ITS RELATED TREATMENT PATTERNS IN CHINA: A REAL-WORLD ELECTRONIC MEDICAL RECORDS DATABASE ANALYSIS

May 1, 2019, 00:00
PNS118 VALUE-BASED REIMBURSEMENT UNDER THE INPATIENT PROSPECTIVE PAYMENT SYSTEM IN JAPAN

May 1, 2019, 00:00
PMH25 REAL-WORLD EVIDENCE INVESTIGATION ON HEALTHCARE UTILIZATION AND COST AMONG NEGATIVE SYMPTOM PATIENTS AND NON-NEGATIVE SYMPTOM PATIENTS WITH SCHIZOPHRENIA IN THE US

May 1, 2019, 00:00
PDB107 EVALUATING THE CONTENT VALIDITY OF THE PROMIS® PHYSICAL FUNCTION SHORT FORMS IN OVERWEIGHT AND OBESE INDIVIDUALS

May 1, 2019, 00:00
PNS172 COMPARISON OF CURRENT AND PREFERRED STATUS OF HTA IMPLEMENTATION IN JORDAN

May 1, 2019, 00:00
PMU80 A SYSTEMATIC REVIEW OF ICER EVALUATIONS FROM 2008 TO 2018: RECENT TRENDS IN EVALUATION PROCESS AND LESSONS LEARNED

May 1, 2019, 00:00
NO Specific Disease - Organizational Practices

May 1, 2019, 00:00
PIH46 OPIOID PRESCRIPTION DRUG UTILIZATION IN CHILDREN AND ADOLESCENTS WITH ASTHMA

May 1, 2019, 00:00
PNS113 THE 2019 UNITED STATES PAYOR LANDSCAPE: TRENDS AND RESULTS FROM SURVEYS ON FORMULARY MANAGEMENT

May 1, 2019, 00:00
PMH37 CLINICAL AND MEDICATION USE CHARACTERISTICS OF A US NATIONAL COHORT OF OLDER DEMENTIA PATIENTS

May 1, 2019, 00:00
PDG17 COST-EFFECTIVENESS OF THE SECOND LINE TREATMENT FOR ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)

May 1, 2019, 00:00
PMH20 THE ECONOMIC BURDEN OF BIPOLAR DISORDER IN THE UNITED STATES: RESULTS FROM A SYSTEMATIC LITERATURE REVIEW

May 1, 2019, 00:00
PMU81 INCORPORATING HEALTH TECHNOLOGY ASSESSMENT INTO LABORATORY MEDICINE AT UW MEDICINE

May 1, 2019, 00:00
PNS145 PATIENTS HAVE LITTLE, IF ANY, INPUT INTO COMMERCIAL HEALTH PLAN SPECIALTY DRUG COVERAGE POLICY DEVELOPMENT

May 1, 2019, 00:00
PMU18 TREATMENT PATTERNS, HEALTH CARE RESOURCE USE, AND FINANCIAL IMPACT OF CADASIL IN THE UNITED STATES

May 1, 2019, 00:00
PNS155 VALUE-BASED CONTRACTING: DO PERSPECTIVES DIFFER BY PAYER TYPE?

May 1, 2019, 00:00
PNS261 HOW DOES MACHINE-LEARNING COMPARE TO AN INCOMING MEDICAL STUDENT IN EXTRACTING OUTCOMES RESULTS FROM ABSTRACTS?

May 1, 2019, 00:00
PND61 LITERATURE REVIEW ON THE POTENTIAL SOCIETAL IMPACT OF DISEASE-MODIFYING THERAPIES IN ALZHEIMERÂ€™S DISEASE

May 1, 2019, 00:00
PCN236 COST-EFFECTIVENESS OF LENALIDOMIDE PLUS LOW DOSE DEXAMETHASONE IN THE CHINESE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA BUT INELIGIBLE FOR STEM CELL TRANSPLANT THERAPY

May 1, 2019, 00:00
PNS91 COMPARING PAYER AND MANUFACTURER EXPERIENCES WITH HCEI AND PIE AFTER PASSAGE OF THE 21ST CENTURY CURES ACT

May 1, 2019, 00:00
PCN294 DERIVATION OF UTILITY VALUES FOR PATIENTS WITH ADVANCED HEPATOCELULAR CARCINOMA BASED ON HRQOL DATA FROM THE PHASE 3 CELESTIAL TRIAL

May 1, 2019, 00:00
PMH18 THE IMPLEMENTATION OF COMPETING RISKS USING DIFFERENT MODELING TECHNIQUES AND STRUCTURES: THE EFFECT ON INCREMENTAL COST-EFFECTIVENESS

May 1, 2019, 00:00
PDG72 DETERMINANTS OF AN EFFICIENT MODEL OF EXTENDED-RELEASE NALTREXONE INITIATION FOR THE TREATMENT OF OPIOID USE DISORDER

May 1, 2019, 00:00
PCV51 A MICROCOSTING STUDY FOR ANGIOPLASTY PROCEDURE: REAL WORLD DATA IN SOUTHERN BRAZIL

May 1, 2019, 00:00
PNS179 HTA IMPLEMENTATION IN MIDDLE EAST AND NORTH AFRICA: COMPARISON OF CURRENT AND PREFERRED STATUS

May 1, 2019, 00:00
PNS265 AUTOMATED DISCOVERY OF COMPARATIVE EFFECTIVENESS HYPOTHESES FROM MEDICAL LITERATURE.

May 1, 2019, 00:00
PMU33 ASSESSING NIGERIAN PHARMACISTS' FAMILIARITY AND EDUCATIONAL NEEDS REGARDING DISASTER EMERGENCY PREPAREDNESS COMPETENCIES

May 1, 2019, 00:00
PNS89 INTERNATIONAL COMPARISON OF THE REMUNERATION OF PHYSICIANS AMONG COUNTRIES WITH BISMARCK AND BEVERIDGE HEALTH CARE SYSTEM

May 1, 2019, 00:00
PDG16 PREDICTING THE COST-EFFECTIVENESS OF GENERIC VERSUS BRAND DABIGATRAN USING PHARMACOMETRIC ESTIMATES AMONG PATIENTS WITH ATRIAL FIBRILLATION

May 1, 2019, 00:00
PDB7 DIABETIC COMPLICATIONS ASSOCIATED WITH SGLT2 AND DPP4 INHIBITORS: A REAL-WORLD APPROACH

May 1, 2019, 00:00
PIN12 ASSESSING KNOWLEDGE ABOUT HAND HYGIENE IN A CITY HOSPITAL, HUNGARY

May 1, 2019, 00:00
Multiple Diseases - Methodological Statistical Research

May 1, 2019, 00:00
Multiple Diseases - Health Policy Regulatory

May 1, 2019, 00:00
PMU35 ECONOMIC BURDEN OF AIR POLLUTION IN COLOMBIA

May 1, 2019, 00:00
PND47 ANNUAL PRESCRIPTION STIMULANT FILL TRENDS: AN ANALYSIS OF 17 STATES UTILIZING MEDICAID CLAIMS DATA

May 1, 2019, 00:00
Individual's Health - Health Policy Regulatory

May 1, 2019, 00:00
PIN6 RELATIONSHIP BETWEEN PHARMACOLOGICAL NON-ADHERENCE AND VIROLOGICAL SUCCESS IN PATIENTS WITH HIV, COLOMBIA

May 1, 2019, 00:00
Diabetes/Endocrine/Metabolic Disorders - Epidemiology Public Health

May 1, 2019, 00:00
PDB112 LITERATURE REVIEW OF PATIENT-REPORTED OUTCOMES (PRO) ASSOCIATED WITH MULTIPLE DAILY INSULIN INJECTION (MDI) THERAPY FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)

May 1, 2019, 00:00
PCN315 CHARACTERISTICS OF REGISTRY PUBLICATIONS IN HEMATOLOGY-ONCOLOGY JOURNALS AND ASSOCIATION WITH IMPACT FACTOR

May 1, 2019, 00:00
PDG89 USING THE REAL WORLD DATA TO IDENTIFY THE ASSOCIATION BETWEEN THE MOST COMMON SYMPTOM CLUSTERS OF DRUG ADRS AND NUMBERS OF DRUGS PER PATIENT REGIMEN IN A MEDICAID POPULATION

May 1, 2019, 00:00
PDG71 ACCESS TO NALOXONE AND PREFERENCES REGARDING ONLINE PURCHASE OF NALOXONE AMONG INDIVIDUALS AFFECTED BY OPIOID ABUSE OR DEPENDENCE

May 1, 2019, 00:00
PDG47 PRESCRIPTION PATTERNS AND INDICATIONS OF FLUOROQUINOLONES IN A GROUP OF AMBULATORY PATIENTS IN COLOMBIA, 2018

May 1, 2019, 00:00
PGI20 A REPORT ON THE QUALITY OF LIFE OF OSTOMATES IN THE NETHERLANDS

May 1, 2019, 00:00
Personalized Information Systems

May 1, 2019, 00:00
PIN63 CUMULATIVE COMPLETION RATES FOR HUMAN PAPILLOMAVIRUS VACCINE (HPV) AMONG CHILDREN, ADOLESCENTS, AND YOUNG ADULTS IN THE UNITED STATES DURING 2006-2016

May 1, 2019, 00:00
PNS228 HEOR AND RWE SOURCING AND PROCUREMENT CHALLENGES AND OPPORTUNITIES: A BENCHMARKING SURVEY

May 1, 2019, 00:00
PMU7 ASSOCIATION OF ADVERSE CHILDHOOD EVENTS AND HEALTH OUTCOMES WITHIN THE BRFSS DATABASE IN PENNSYLVANIA

May 1, 2019, 00:00
PND63 IMPACT OF ORAL DISEASE MODIFYING MEDICATION UTILIZATION ON MULTIPLE SLCEROSIS TREATMENT LANDSCAPE: TRENDS OVER THE PAST DECADE

May 1, 2019, 00:00
PIN31 DOLUTEGRAVIR PLUS LAMIVUDINE FOR THE TREATMENT OF ART NAIVE ADULTS LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV): A US COST-UTILITY ANALYSIS

May 1, 2019, 00:00
PMU50 COMPARING UTILIZATION, COST AND QUALITY IN DUAL ELIGIBLE MEDICARE ADVANTAGE AND FEE-FOR-SERVICE MEDICARE BENEFICIARIES

May 1, 2019, 00:00
PIN81 FACTORS INFLUENCING MENINGOCOCCAL VACCINATION UPTAKE AMONG ADOLESCENTS IN THE UNITED STATES

May 1, 2019, 00:00
PIT10 COST AND COST-EFFECTIVENESS IMPLICATIONS OF UTILIZING IMMEDIATE ACUTE MAGNETIC RESONANCE IMAGING IN THE MANAGEMENT OF PATIENTS WITH SUSPECTED SCAPHOID FRACTURE AND NEGATIVE INITIAL RADIOGRAPHS: RESULTS FROM A RANDOMIZED CLINICAL TRIAL ...

May 1, 2019, 00:00
PCN282 EXPLORATORY ANALYSIS OF ADHERENCE TO ANTICANCER THERAPIES IN METASTATIC RENAL CELL CARCINOMA IN THE UNITED STATES (US)

May 1, 2019, 00:00
PND6 PARKINSON'S DISEASE PROGRESSION: A SYSTEMATIC LITERATURE REVIEW

May 1, 2019, 00:00
Cardiovascular Disorders - Economic Evaluation

May 1, 2019, 00:00
PIN8 PROTEASE INHIBITOR EXPOSURE AND THE RISK OF DEVELOPING DIABETES MELLITUS IN TREATED HIV SEROPOSITIVE PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

May 1, 2019, 00:00
PNS211 ASSESSING POPULATION-ADJUSTED INDIRECT COMPARISON METHODS (MATCHING-ADJUSTED INDIRECT COMPARISON AND SIMULATED TREATMENT COMPARISON) USING MONTE-CARLO SIMULATIONS

May 1, 2019, 00:00
PNS267 WINNING BEYOND THE REGULATOR. COMPARING THE VALUE OF DIFFERENT DATA TYPES FROM PAYER AND CLINICIAN PERSPECTIVES TO SUPPORT PRESCRIBING AND REIMBURSEMENT

May 1, 2019, 00:00
PCN277 SYSTEMATIC LITERATURE REVIEW OF UTILITY STUDIES IN PATIENTS WITH ADVANCED OR METASTATIC HEPATOCELLULAR CANCER

May 1, 2019, 00:00
PCV40 HEALTHCARE RESOURCE UTILIZATION AND COSTS ASSOCIATED WITH ABNORMAL POTASSIUM LEVELS AMONG US PATIENTS WITH SYSTOLIC AND DIASTOLIC HEART FAILURE: A POPULATION-BASED COHORT STUDY

May 1, 2019, 00:00
PNS263 FREQUENCIES OF CONSECUTIVELY MISSED DAILY DOSES OF ESCITALOPRAM

May 1, 2019, 00:00
PDB67 DIABETES MELLITUS : A SYNONYM TO FUNCTIONAL HYPOPARATHYROIDISM

May 1, 2019, 00:00
PNS137 ARE MEDICAL DIRECTORS' AND PHARMACY DIRECTORS' ATTITUDES DIFFERENT TOWARDS PROACTIVE HCEI AND PIE?

May 1, 2019, 00:00
PMU24 BUDGET IMPACT OF SECUKINUMAB FOR THE TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS FROM THE COLOMBIAN HEALTHCARE PERSPECTIVE

May 1, 2019, 00:00
PCN259 SHOULD HEALTH STATE UTILITY VALUES (HSUVS) IN CANCER IMMUNOTHERAPIES (IOS) BE ANALYZED BY TIME TO DEATH (TTD) OR PROGRESSION STATUS? RESULTS OF A SIMULATION STUDY

May 1, 2019, 00:00
PIN7 A NETWORK META-ANALYSIS OF THE EFFICACY AND SAFETY OF BALOXAVIR MARBOXIL VERSUS NEURAMINIDASE INHIBITORS IN THE TREATMENT OF INFLUENZA VIRUS INFECTION IN HIGH-RISK PATIENTS

May 1, 2019, 00:00
PMU67 INNOVATIVE APPROACHES TO DISEASE MANAGEMENT: BCBSLA'S ZERO DOLLAR CO-PAY PROGRAM FOR MEMBERS WITH CHRONIC DISEASES

May 1, 2019, 00:00
PMU69 INTERPROFESSIONAL CARE TRANSITIONS CLINIC IMPACT ON HEALTHCARE COSTS

May 1, 2019, 00:00
Cardiovascular Disorders - Health Technology Assessment

May 1, 2019, 00:00
PMS52 REAL-WORLD OUTCOMES AND COST OF MANAGEMENT OF OSTEOPOROTIC FRACTURES IN ONTARIO, CANADA

May 1, 2019, 00:00
PIN54 ANALYSIS OF VACCINE ADVERSE EVENTS IN PREGNANT WOMEN IN THE US (2014-2018)

May 1, 2019, 00:00
PCV82 FACTORS ASSOCIATED WITH UNPLANNED 30-DAY HEART FAILURE READMISSION RATES AMONG MEDICARE AND MEDICAID PATIENTS IN TEXAS

May 1, 2019, 00:00
PMU75 EMERGING TRENDS IN US HTA: A SYSTEMATIC REVIEW OF ICER VALUE ASSESSMENTS TO IDENTIFY FACTORS ASSOCIATED WITH RECOMMENDATIONS

May 1, 2019, 00:00
Gastrointestinal Disorders - Patient-Centered Research

May 1, 2019, 00:00
PIH57 KNOWLEDEGES AND EXPERIENCES OF PREGNANT WOMEN ON PRENATAL CARE PROGRAMS OF A SUBSIDIZED HEALTH CARE COMPANY FROM THE CARIBBEAN REGION OF COLOMBIA: A QUALITATIVE ANALYSIS

May 1, 2019, 00:00
PDG41 TRENDS IN PRESCRIBED INPATIENT-SURGERY OPIOID USE AND EXPENSES IN THE U.S. USING 2011-2015 MEDICAL EXPENDITURE PANEL SURVEY

May 1, 2019, 00:00
AD3 FOOD INSECURE CANCER SURVIVORS ARE MORE LIKELY TO FORGO OR DELAY MEDICAL CARE

May 1, 2019, 00:00
PIH34 IMPACT OF ENDOMETRIOSIS DIAGNOSTIC DELAYS ON HEALTHCARE COSTS: A RETROSPECTIVE COHORT ANALYSIS

May 1, 2019, 00:00
PND9 EVENT-FREE SURVIVAL AND MOTOR MILESTONE ACHIEVEMENT FOLLOWING AVXS-101 AND NUSINERSEN INTERVENTIONS CONTRASTED TO NATURAL HISTORY FOR TYPE I SPINAL MUSCULAR ATROPHY PATIENTS

May 1, 2019, 00:00
PDG70 SHORT DURATION OF CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (CSDMARDS) BEFORE AND AFTER BECOMING A CSDMARD INADEQUATE RESPONDER (IR) IN RHEUMATOID ARTHRITIS (RA) PATIENTS

May 1, 2019, 00:00
PCN317 REAL-WORLD STUDY OF METASTATIC MERKEL CELL CARCINOMA PATIENTS RECEIVING CHECKPOINT INHIBITORS (CPIS) VS. CHEMOTHERAPY TREATMENTS

May 1, 2019, 00:00
PND23 SYSTEMATIC LITERATURE REVIEW OF ECONOMIC AND STATISTICAL MODELS OF AGITATION IN NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS

May 1, 2019, 00:00
PDB126 COMPARATIVE HEALTHCARE COSTS AND MEDICATION BURDEN IN REAL-WORLD PATIENTS AUGMENTING METFORMIN MONOTHERAPY WITH EMPAGLIFLOZIN FROM THE EMPAGLIFLOZIN COMPARATIVE EFFECTIVENESS AND SAFETY (EMPRISE) STUDY

May 1, 2019, 00:00
PMU54 DEVELOPMENT OF EXTENDED PHARMACY REIMBURSEMENT PROGRAM IN UKRAINE: EVIDENCE FROM THE ANALYSIS OF CENTRAL PROCUREMENT PROGRAMS

May 1, 2019, 00:00
PCN268 ASSOCIATION BETWEEN ADHERENCE TO ORAL HORMONE THERAPY AND TYPE OF ORAL HORMONE THERAPY IN MEDICARE BENEFICIARIES WITH HORMONE RECEPTOR POSITIVE BREAST CANCER

May 1, 2019, 00:00
PMH28 THE INCREASING RATE OF CHILDHOOD MENTAL ILLNESSES AND ASSOCIATED HEALTHCARE COSTS IN THE UNITED STATES: TRENDS OVER THE PAST DECADE

May 1, 2019, 00:00
PIH41 VARIATION IN POLYCYSTIC OVARY SYNDROME PATIENT CHARACTERISTICS BY BODY MASS INDEX: A REAL-WORLD ANALYSIS USING A CLAIMS AND ELECTRONIC HEALTH RECORD LINKED DATABASE

May 1, 2019, 00:00
PCN296 DEVELOPMENT OF SCIENTIFIC GUIDELINES FOR USE OF THE EORTC ITEM LIBRARY IN CANCER CLINICAL TRIALS

May 1, 2019, 00:00
PIH33 COST MINIMIZATION ANALYSIS OF HIGH PURITY URINARY HUMAN FOLLICLE-STIMULATING HORMONE FOR THE CONTROLLED OVARIAN STIMULATION IN IN-VITRO FERTILIZATION IN CHINA

May 1, 2019, 00:00
PIT2 HOSPITAL LENGTH OF STAY, COMPLICATIONS, AND HEALTHCARE RESOURCE UTILIZATION ASSOCIATED WITH OPEN REDUCTION INTERNAL FIXATION FOR HUMERUS FRACTURES

May 1, 2019, 00:00
PCN299 COST TREND ANALYSIS OF BREAST CANCER DRUGS IN LEBANON USING A PRIVATE PAYER DATA SET

May 1, 2019, 00:00
PNS15 PRAGMATIC ARTIFICIAL INTELLIGENCE-BASED REFERENCE SCREENING IN SYSTEMATIC REVEIWS. ARE TWO ROBOTS BETTER THAN ONE?

May 1, 2019, 00:00
Neurological Disorders - Health Technology Assessment

May 1, 2019, 00:00
PND53 TREATMENT PATTERNS AND PROGNOSIS OF PATIENTS WITH AN INCIDENT DRUG-INDUCED PARKINSONISM

May 1, 2019, 00:00
Cardiovascular Disorders - Clinical Outcomes

May 1, 2019, 00:00
Diabetes/Endocrine/Metabolic Disorders - Economic Evaluation

May 1, 2019, 00:00
PGI16 MAJOR CAUSES OF MORTALITY AMONG HOSPITALIZED DECOMPENSATED CIRRHOSIS PATIENTS: IMPLICATIONS FOR DISEASE MANAGEMENT

May 1, 2019, 00:00
PDB50 SELF-MONITORING BLOOD GLUCOSE AND ECONOMIC OUTCOMES IN PEOPLE WITH DIABETES

May 1, 2019, 00:00
PNS150 DISABILITY AS DEFINED BY MARKET ACCESS AND HEALTH ECONOMICS AND OUTCOMES RESEARCH PROFESSIONALS: MIXED METHODS.

May 1, 2019, 00:00
PDB38 REAL-WORLD COMPARISON OF HOSPITALIZATION COSTS FOR HEART FAILURE IN T2DM PATIENTS WITH CARDIOVASCULAR DISEASE TREATED WITH CANAGLIFLOZIN VERSUS OTHER ANTIHYPERGLYCEMIC AGENTS

May 1, 2019, 00:00
PMU22 ECONOMIC ANALYSIS OF USING COURIER SYSTEM ALONE COMPARED WITH A COMBINATION OF BACTEC MACHINES AND COURIER SYSTEM TO OBTAIN BLOOD SAMPLE RESULTS AT LOWER FACILITIES: A CASE OF THE EID PROJECT AT THE INFECTIOUS DISEASES INSTITUTE IN UG ...

May 1, 2019, 00:00
PCN302 COMPARING SERVICE UTILIZATION AND COSTS FOR MEDICARE FFS PATIENTS WITH METASTATIC PANCREATIC CANCER BY CHEMOTHERAPY REGIMEN AND LINE OF THERAPY

May 1, 2019, 00:00
PMS28 QUALITY OF LIFE AND THE RELATIONSHIP WITH FAMILY INCOME IN PATIENTS WITH RHEUMATOID ARTHRITIS

May 1, 2019, 00:00
PMU4 ANALISIS OF REAL WORLD EVIDANCE OF PERIODONTAL DISEASES IN PATIENTS WITH CHRONIC RHEUMATIC HEART DISEASE (CRHD) IN UKRAINE

May 1, 2019, 00:00
PMS13 ASSOCIATION OF OPIOID ANALGESIC USE ON EMERGENCY DEPARTMENT LENGTH OF STAY AMONG LOW BACK PAIN PATIENTS: A UNITED STATES NATIONAL ANALYSIS

May 1, 2019, 00:00
PCN311 CLINICAL CHARACTERISTICS, TREATMENT PATTERNS, AND HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH ADVANCED UROTHELIAL CARCINOMA AFTER PROGRESSION ON PLATINUM-BASED THERAPY: A MEDICAL RECORD REVIEW STUDY IN THE UNITED STATES AND CANA ...

May 1, 2019, 00:00
Abstracts Disclaimer

May 1, 2019, 00:00
PMU63 RETROSPECTIVE ANALYSIS OF CHARACTERISTICS AND HEALTH RESOURCES UTILIZATION (HRU) OF MULTI-CONSULTANT PATIENTS IN AN INSURER

May 1, 2019, 00:00
Medical Devices - Real World Data Information Systems

May 1, 2019, 00:00
PNS46 INTERVENTION USING PHARMACLOUD SYSTEM TO REDUCE POLYPHARMACY AND HEALTHCARE SPENDING

May 1, 2019, 00:00
Individual's Health - Health Technology Assessment

May 1, 2019, 00:00
PCV38 A PHARMACOECONOMIC EVALUATION ON IRBESARTAN AND LEVOAMLODIPINE IN STROKE AND MYOCARDIAL INFARCTION PREVENTION AMONG HYPERTENSION PATIENTS IN CHINA

May 1, 2019, 00:00
Multiple Diseases - Clinical Outcomes

May 1, 2019, 00:00
PIN87 EVALUATION OF THE EFFECTIVENESS OF CLINICAL PHARMACISTSâ€™ CONSULTATION IN THE TREATMENT OF INFECTIOUS DISEASES: A SINGLE-ARM, PROSPECTIVE COHORT STUDY

May 1, 2019, 00:00
PND28 A BUDGET IMPACT ANALYSIS OF CENOBAMATE FOR THE TREATMENT OF REFRACTORY PARTIAL-ONSET EPILEPSY

May 1, 2019, 00:00
PCV52 PRESCRIBING AND EXPENDITURES FOR PCSK9 INHIBITORS IN THE MEDICARE PART D POPULATION IN 2016

May 1, 2019, 00:00
PMS48 A LANDSCAPE ASSESSMENT OF STAND-ALONE PATIENT-REPORTED OUTCOME (PRO) MEASURES USED IN CLINICAL TRIALS FOR RHEUMATOID ARTHRITIS (RA)

May 1, 2019, 00:00
PCV5 PREVALENCE OF FOUR STATIN BENEFIT GROUPS IN A POPULATION OF THE CARIBBEAN REGION OF COLOMBIA

May 1, 2019, 00:00
PCV2 UNMET NEEDS FOR LIPID-LOWERING THERAPY IN CARDIOVASCULAR EVENTS REDUCTION

May 1, 2019, 00:00
PNS212 AUTOMATING VARIABLE SELECTION IN META-REGRESSION

May 1, 2019, 00:00
PMU102 MECHANISMS OF ENGAGEMENT IN PRESCRIPTION MEDICATION-RELATED DECISION MAKING: INFLUENCES OF EXPOSURE TO DIRECT-TO-CONSUMER ADVERTISING (DTCA)

May 1, 2019, 00:00
PIN86 PATIENT- AND PROVIDER-LEVEL CHARACTERISTICS AND OUTCOMES ASSOCIATED WITH INAPPROPRIATE ANTIBIOTIC PRESCRIBING IN UNCOMPLICATED ACUTE ADULT BRONCHITIS IN THE OUTPATIENT SETTING

May 1, 2019, 00:00
PMH5 HEALTH-RELATED QUALITY OF LIFE IN VETERANS AND NON-VETERANS WITH DEPRESSION

May 1, 2019, 00:00
PIN41 HEALTH AND ECONOMIC BURDEN ASSOCIATED WITH 15-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV15) SEROTYPES IN CHILDREN IN THE UNITED STATES

May 1, 2019, 00:00
PMU29 IMPACT OF UNCONVENTIONAL NATURAL GAS OR PETROLEUM HYDRAULIC FRACTURING â€œFRACKINGâ€ ON HUMAN HEALTH: A SYSTEMATIC REVIEW OF THE LITERATURE

May 1, 2019, 00:00
PMU78 METHODOLOGICAL ISSUES IN THEORY AND PRACTICE: NICE SCIENTIFIC ADVICE EXPERIENCE WITH ADVANCED THERAPY MEDICINAL PRODUCTS

May 1, 2019, 00:00
PIH51 A PILOT STUDY ASSESSING THE IMPACT OF ADVANCED PHARMACISTS-DELIVERED PATIENT-CENTERED CARE ON HEALTH OUTCOMES FOR HOSPITALIZED GERIATRICS PATIENTS

May 1, 2019, 00:00
PDB46 EVALUATING THE LONG-TERM COST-UTILITY OF INSULIN DEGLUDEC VERSUS INSULIN GLARGINE U100 IN BASAL-BOLUS REGIMENS FOR TYPE 2 DIABETES IN CHINA

May 1, 2019, 00:00
PCV74 COST REDUCTION AFTER THE INDUCTION OF THE RESIDENT ENLIGHTMENT BASED ON MEDICAL CHECKUP IN A JAPANESE RURAL AREA

May 1, 2019, 00:00
PNS16 EVALUATION OF THE MULTICRITERIA METHODOLOGY FOR THE USE IN EVALUATION OF HEALTH TECHNOLOGIES. ADVANTAGES AND DISADVANTAGES OF THE METHOD

May 1, 2019, 00:00
PMU40 RISK FACTORS OF FLUOROPYRIMIDINE-INDUCED CARDIOTOXICITY AMONG CANCER SURVIVORS: A SYSTEMATIC REVIEW

May 1, 2019, 00:00
PND32 EVALUATION OF GLOBAL IMPROVEMENT AND LIFETIME COSTS OF TREATING TARDIVE DYSKINESIA SHOWS TREATMENT WITH VALBENAZINE DOMINATES DEUTETRABENAZINE

May 1, 2019, 00:00
PMH2 PREDICTORS OF TREATMENT RESISTANT DEPRESSION AMONG ADULTS WITH CHRONIC NON-CANCER PAIN CONDITIONS: A MACHINE LEARNING APPROACH

May 1, 2019, 00:00
Infectious Diseases - Health Policy Regulatory

May 1, 2019, 00:00
PMD35 POTENTIAL COST SAVINGS IN TREATMENT OF CHRONIC WOUNDS WITH FIRST WOUND BED CONFORMING WOUND DRESSING

May 1, 2019, 00:00
PCV23 HEALTHCARE RESOURCE USE AND COSTS FOLLOWING CATHETER ABLATION IN PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (PSVT) PATIENTS AGE 65

May 1, 2019, 00:00
PMS19 POTENTIAL COST-SAVINGS DUE TO THE APPLICATION OF A CENTER OF EXCELLENCE CARE MODEL IN RHEUMATOID ARTHRITIS IN COLOMBIA

May 1, 2019, 00:00
PMH59 WHAT MOTIVATES PEOPLE WITH SUBSTANCE USE DISORDERS TO PURSUE TREATMENT? A PATIENT-CENTERED APPROACH TO UNDERSTANDING PATIENT EXPERIENCES AND PATIENT-PROVIDER INTERACTIONS

May 1, 2019, 00:00
PDB6 EFFECTIVENESS OF INSULIN PLUS OFF LABEL USE OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS VERSUS INSULIN ALONE IN TYPE 1 DIABETES: A REAL-WORLD OBSERVATIONAL ANALYSIS

May 1, 2019, 00:00
PND55 SOCIETAL BURDEN OF MULTIPLE SCLEROSIS IN THE BRAZILIAN SOCIAL SECURITY SYSTEM

May 1, 2019, 00:00
PNS31 QUALITY OF PUBLISHED REAL WORLD EVIDENCE ARTICLES BASED ON RETROSPECTIVE DATABASE ANALYSIS USING THE STRWE-RETRO CHECKLIST

May 1, 2019, 00:00
PCN293 REAL-WORLD PRODUCTIVITY, HEALTHCARE RESOURCE UTILIZATION (HCRU) AND QUALITY OF LIFE (QOL) IN PATIENTS RECEIVING FIRST-LINE TREATMENT FOR ADVANCED GASTRIC CANCER (GC) IN CANADA AND EUROPE

May 1, 2019, 00:00
PMU97 COVERAGE AND REVIEWS OF MEDICAL DEVICES, LABORATORY, AND DIAGNOSTIC TESTING BY U.S. HEALTH PLANS

May 1, 2019, 00:00
PNS44 A FRAMEWORK FOR ESTIMATING THE ECONOMIC BURDEN OF MEDICATION ERRORS WITHIN US ACUTE CARE FACILITIES

May 1, 2019, 00:00
PCV8 HEALTH CARE RESOURCE UTILIZATION AND COSTS AMONG PATIENTS NEWLY TREATED FOR PULMONARY ARTERIAL HYPERTENSION IN A REAL-WORLD DATABASE REPRESENTING A LARGE US HEALTH PLAN

May 1, 2019, 00:00
PNS84 EAMS VS. ATU: COMPARING EARLY ACCESS TO UNLICENSED MEDICINES IN UK AND FRANCE

May 1, 2019, 00:00
PMU3 PUBLICLY DISCLOSED OUTCOMES-BASED CONTRACTS IN UNITED STATES

May 1, 2019, 00:00
PMU52 STEP THERAPY AS AN APPROACH TO ADDRESS HEALTH CARE COSTS: PRINCIPLES, LEGISLATION AND PATIENT OUTCOMES

May 1, 2019, 00:00
AD2 EXAMINING THE ASSOCIATION BETWEEN PROVIDER OUTREACH AND PATIENTS' STATIN REFILL BEHAVIOR FOR PATIENTS WITHIN A MEDICARE ADVANTAGE WITH PRESCRIPTION DRUG (MAPD) COVERAGE POPULATION

May 1, 2019, 00:00
PDB118 EVIDENCE MAPPING OF INSULIN MANAGEMENT DRIVERS TO ECONOMIC AND CLINICAL OUTCOMES

May 1, 2019, 00:00
PMU12 SCALABLE DECISION-ANALYTIC MODELLING WITH INFLUENCE DIAGRAMS

May 1, 2019, 00:00
PNS253 HOW TO IDENTIFY AND DEAL WITH NUMERICAL INCONSISTENCIES IN ELICITED HEALTH STATE UTILITIES

May 1, 2019, 00:00
PDB122 ANTIDIABETIC DRUG PERSISTENCE AND SWITCHING PATTERNS: A RETROSPECTIVE CLAIMS STUDY

May 1, 2019, 00:00
PMS24 NATIONWIDE, REAL-WORLD HEALTH INSURANCE TREATMENT COST OF SCOLIOSIS IN HUNGARY: A COST OF ILLNESS STUDY

May 1, 2019, 00:00
Back to the Future With Value in Health

May 1, 2019, 00:00
PDB128 REDUCED HEALTHCARE UTILIZATION IN PATIENTS USING EMPAGLIFLOZIN: AN INTERIM ANALYSIS FROM THE EMPAGLIFLOZIN COMPARATIVE EFFECTIVENESS AND SAFETY (EMPRISE) STUDY

May 1, 2019, 00:00
PCN267 PATIENT SUPPORT PROGRAMS BECOMING INCREASINGLY PATIENT-CENTRIC WITHIN COMPETITIVE IMMUNO-ONOLOGY LANDSCAPE

May 1, 2019, 00:00
Musculoskeletal Disorders - Patient-Centered Research

May 1, 2019, 00:00
PCV39 RADIOFREQUENCY CATHETER ABLATION WITH WARFARIN VERSUS ANTIARRHYTHMIC DRUGS WITH NEW ORAL ANTICOAGULANTS FOR THE TREATMENT OF PAROXYSMAL ATRIAL FIBRILLATION IN CHINA: A COST- EFFECTIVENESS ANALYSIS

May 1, 2019, 00:00
PIN44 A MODEL TO EVALUATE THE IMPACT OF HOSPITAL-BASED INTERVENTIONS TARGETING FALSE-POSITIVE BLOOD CULTURES ON ECONOMIC AND CLINICAL OUTCOMES

May 1, 2019, 00:00
PMU68 BCBSLA EVALUATION OF A NURSE FOCUSED DISEASE MANAGEMENT PROGRAM IN LOUISIANA

May 1, 2019, 00:00
PROMIS Adult Health Profiles: Efficient Short-Form Measures of Seven Health Domains

May 1, 2019, 00:00
PDG6 HEALTHCARE RESOURCE UTILIZATION, COST, AND TREATMENT PERSISTENCE AMONG TREATMENT-NAIVE PAH PATIENTS INITIATING MONOTHERAPY VS. COMBINATION THERAPY

May 1, 2019, 00:00
PIH29 MODELING THE TOTAL AND NET COST OF DEMENTIA IN THE UNITED STATES

May 1, 2019, 00:00
PNS262 GLOBAL TRENDS IN REGULATORY LEGISLATION FOR POST MARKETING SURVEILLANCE (PMS) REAL-WORLD EVIDENCE (RWE) STUDIES AND THE SECONDARY USE OF HEALTH DATA IN PMS STUDIES.

May 1, 2019, 00:00
PIH60 COMPARATIVE EFFICACY AND SAFETY OF PHOSPHODIESTERASE 5 INHIBITORS FOR ERECTILE DYSFUNCTION IN MEN WITH COMORBIDITIES: SYSTEMATIC REVIEW WITH NETWORK META-ANALYSIS

May 1, 2019, 00:00
PNS124 FEASIBILITY OF MULTI-INDICATION PRICING: A TARGETED REVIEW OF THE INTERNATIONAL LITERATURE

May 1, 2019, 00:00
PNS207 HOW TO CAPTURE THE IMPACT OF SELECTION BIASES IN CLINICAL PRACTICE ON THE AVERAGE EFFICACY OF TREATMENT

May 1, 2019, 00:00
PMS23 BUDGET IMPACT ANALYSIS OF TERIPARATIDE IN THE TREATMENT FOR POSTMENOPAUSAL OSTEOPOROSIS IN QINGDAO, CHINA

May 1, 2019, 00:00
PMD48 IMPACT OF SURGICEL ON SURGICAL OUTCOMES AND HOSPITAL COSTS ASSOCIATED WITH LUMBAR SURGERY IN A CHINESE TIER III TERTIARY CARE HOSPITAL

May 1, 2019, 00:00
PCN304 CARDIAC MONITORING AMONG CHEMOTHERAPY,TARGETED THERAPY AND RADIATION THERAPY TREATED BREAST CANCER PATIENTS

May 1, 2019, 00:00
PMS26 COST-EFFECTIVENESS OF SEQUENTIAL TREATMENT WITH ABALOPARATIDE FOLLOWED BY ALENDRONATE VS ALENDRONATE MONOTHERAPY FOR THE PREVENTION OF FRACTURES IN POSTMENOPAUSAL US WOMEN AT INCREASED RISK OF FRACTURE

May 1, 2019, 00:00
PDG63 VARIATION OF PHARMACOTHERAPIES FOR OPIOID USE DISORDER ACROSS STATE MEDICAID PROGRAMS

May 1, 2019, 00:00
PDB4 VARIATION IN THE ASSOCIATION BETWEEN METABOLIC SYNDROME AND NON-ALCOHOLIC FATTY LIVER DISEASE BY RACE

May 1, 2019, 00:00
PNS215 A COMPARISON OF R PACKAGES FOR PREDICTION AND SIMULATION OF MULTI-STATE MODELS FOR COST-EFFECTIVENESS ANALYSIS

May 1, 2019, 00:00
PCV50 REAL-WORLD ECONOMIC OUTCOMES COMPARISON BETWEEN THERMOCOOL SMARTTOUCH® SF CATHETER AND THERMOCOOL SMARTTOUCH® CATHETER AMONG PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING ABLATION IN AN OUTPATIENT SETTING: RESULTS FROM MULTI-HOSPITAL D ...

May 1, 2019, 00:00
PDG54 UNDERSTANDING TEXAS COMMUNITY PHARMACISTS' ATTITUDES TOWARD MANDATED PDMP USE AND SEVEN DAY PRESCRIBING LIMITS ON OPIOID PRESCRIPTIONS FOR ACUTE NON-CANCER PAIN

May 1, 2019, 00:00
PMH16 ECONOMIC BURDEN ASSOCIATED WITH NON-COMMUNICABLE DISEASES AMONG ADULTS WITH DEPRESSION AND ANXIETY IN THE UNITED STATES.

May 1, 2019, 00:00
Drug Related Public Health Studies

May 1, 2019, 00:00
PND89 PERSISTENCE TO ORAL AND INJECTABLE MULTIPLE SCLEROSIS DISEASE-MODIFYING THERAPIES

May 1, 2019, 00:00
Individual's Health - Methodological Statistical Research

May 1, 2019, 00:00
PCV16 MANAGEMENT OF GASTROINTESTINAL AND UROGENITAL BLEEDING EVENTS IN PATIENTS WITH NON VALVULAR ATRIAL FIBRILLATION TREATED WITH DABIGATRAN ETEXILATE EARLY AFTER APPROVAL

May 1, 2019, 00:00
PCN290 ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONS (ALLO-HSCT) ARE ASSOCIATED WITH POOR QUALITY OF LIFE (QOL) AND ECONOMIC BURDEN DUE TO GRAFT-VERSUS-HOST DISEASE (GVHD) COMPLICATIONS: RESULTS OF A SYSTEMATIC LITERATURE REVIEW (SLR) ...

May 1, 2019, 00:00
Cardiovascular Disorders - Health Service Delivery Process of Care

May 1, 2019, 00:00
PNS81 STATUS OF EXPANDED ACCESS PROGRAM (EAP) REGISTRATION INTO CLINICALTRIALS.GOV FOLLOWING 21ST CENTURY CURES ACT

May 1, 2019, 00:00
PNS27 RISK-BENEFIT ASSESSMENT USING THE LIKELIHOOD HELPED OR HARMED RATIO: SIMILARITIES AND DIFFERENCES WITH INCREMENTAL COST-EFFECTIVENESS RATIOS

May 1, 2019, 00:00
PDG5 COMMONLY REPORTED ADVERSE EVENTS ASSOCIATED WITH ANTICOAGULANTS USING FDA ADVERSE EVENT REPORTING SYSTEM DATABASE 2012-2018

May 1, 2019, 00:00
PIN9 CLINICAL PRACTICE EXPERIENCE WITH TENOFOVIR ALAFENAMIDE (TAF) FOR TREATMENT OF HEPATITIS B IN THE US

May 1, 2019, 00:00
PMS18 COST-EFFECTIVENESS OF TOFACITINIB FOR PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS IN CHINA

May 1, 2019, 00:00
PIH12 BURDEN OF ADVERSE DRUG EVENTS (ADE) DURING HOSPITALIZATION IN OLDER ADULTS- A CROSS SECTIONAL ANALYSIS USING NATIONWIDE READMISSION DATABASE

May 1, 2019, 00:00
PIH47 HEMOLYTIC NEONATAL HYPERBILIRUBINEMIA AMONG EARLY PRETERM NEWBORNS: PREVALENCE, TREATMENT PATTERNS AND BURDEN OF ILLNESS

May 1, 2019, 00:00
PIN46 VAX-THE-NATION: A BUDGET IMPACT ANALYSIS OF INCREASED MEASLES, MUMPS AND RUBELLA VACCINATION UPTAKE IN THE US

May 1, 2019, 00:00
NO Specific Disease - Health Service Delivery Process of Care

May 1, 2019, 00:00
PNS10 INNOVATIVE PHARMACEUTICAL PRICING AND REIMBURSEMENT SCHEMES IN THE US, A CAUTIONARY TALES FROM ABROAD

May 1, 2019, 00:00
Personalized Precision Medicine - Clinical Outcomes

May 1, 2019, 00:00
PNS186 PERCEPTIONS AMONG COMMUNITY ONCOLOGISTS AND RHEUMATOLOGISTS ON DIRECT TO CONSUMER ADVERTISING (DTCA) IN HEALTHCARE

May 1, 2019, 00:00
PNS90 POLICY CHANGES AND IMPACT ON PRICING AND ACCESS OF DRUGS IN US

May 1, 2019, 00:00
PND17 HEALTHCARE RESOURCE UTILIZATION ASSOCIATED WITH PARKINSON'S DISEASE: A LONGITUDINAL STUDY

May 1, 2019, 00:00
PDG19 COST-EFFECTIVENESS OF INTRANASAL NALOXONE DISTRIBUTION TO HIGH RISK PRESCRIPTION OPIOID USERS

May 1, 2019, 00:00
NO Specific Disease - Health Policy Regulatory

May 1, 2019, 00:00
Diabetes/Endocrine/Metabolic Disorders - Health Technology Assessment

May 1, 2019, 00:00